-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Checkpoint Therapeutics, Inc. quarterly/annual Revenues history and growth rate from 2022 to 2023.
- Checkpoint Therapeutics, Inc. Revenues for the quarter ending June 30, 2024 was $41K, a 32.3% increase year-over-year.
- Checkpoint Therapeutics, Inc. annual Revenues for 2023 was $103K, a 46.4% decline from 2022.